Elinore F McCance-Katz

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Untreated HIV infection is associated with higher blood alcohol levels
    Elinore F McCance-Katz
    Department of Psychiatry, Addiction Medicine Research, University of California San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 60:282-8. 2012
  2. pmc Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients
    Elinore F McCance-Katz
    University of California San Francisco, San Francisco, CA 94110, USA
    Drug Alcohol Depend 118:326-34. 2011
  3. pmc Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco General Hospital, United States
    Life Sci 88:953-8. 2011
  4. doi request reprint Effect of cocaine use on methadone pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:47-52. 2010
  5. doi request reprint Effect of cocaine use on buprenorphine pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:38-46. 2010
  6. pmc Lack of clinically significant drug interactions between nevirapine and buprenorphine
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, California, USA
    Am J Addict 19:30-7. 2010
  7. pmc Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, San Francisco, California, USA
    Am J Addict 19:4-16. 2010
  8. pmc Methadone, buprenorphine, and street drug interactions with antiretroviral medications
    Valerie A Gruber
    San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, Ward 93 95, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 7:152-60. 2010
  9. pmc Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, CA, USA
    Clin Infect Dis 54:414-23. 2012
  10. pmc Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir
    Jennifer Baker
    Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA
    Am J Addict 19:17-29. 2010

Collaborators

Detail Information

Publications18

  1. pmc Untreated HIV infection is associated with higher blood alcohol levels
    Elinore F McCance-Katz
    Department of Psychiatry, Addiction Medicine Research, University of California San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 60:282-8. 2012
    ..This pilot study examines the relationship of untreated HIV infection to blood alcohol concentrations (BAC) relative to BAC after initiation of antiretroviral therapy (ART)...
  2. pmc Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients
    Elinore F McCance-Katz
    University of California San Francisco, San Francisco, CA 94110, USA
    Drug Alcohol Depend 118:326-34. 2011
    ....
  3. pmc Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco General Hospital, United States
    Life Sci 88:953-8. 2011
    ....
  4. doi request reprint Effect of cocaine use on methadone pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:47-52. 2010
    ..09) and more rapid methadone clearance (p = .08). Regular cocaine use may adversely impact treatment outcomes for opioid dependence in those receiving methadone maintenance by decreasing methadone exposure...
  5. doi request reprint Effect of cocaine use on buprenorphine pharmacokinetics in humans
    Elinore F McCance-Katz
    Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
    Am J Addict 19:38-46. 2010
    ..Regular cocaine users were younger (p = .0007), and used more heroin (p = .004) and cocaine (p < .0001). Regular cocaine use may result in lower buprenorphine plasma concentrations with potential for adverse clinical outcomes...
  6. pmc Lack of clinically significant drug interactions between nevirapine and buprenorphine
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, California, USA
    Am J Addict 19:30-7. 2010
    ..Buprenorphine did not alter nevirapine pharmacokinetics. Dose adjustments of either buprenorphine or nevirapine are not likely to be necessary when these drugs are coadministered for the treatment of opiate dependence and HIV disease...
  7. pmc Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
    Elinore F McCance-Katz
    Department of Psychiatry, University of California, San Francisco, San Francisco, California, USA
    Am J Addict 19:4-16. 2010
    ..A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area...
  8. pmc Methadone, buprenorphine, and street drug interactions with antiretroviral medications
    Valerie A Gruber
    San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, Ward 93 95, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 7:152-60. 2010
    ..Further, there are many frequently used medications in treatment of complications of HIV disease that have not been studied. There is need for continuing research to define these drug interactions and their clinical significance...
  9. pmc Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, CA, USA
    Clin Infect Dis 54:414-23. 2012
    ..This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence treatment and pain management, and the protease inhibitors (PIs) darunavir-ritonavir and fosamprenavir-ritonavir...
  10. pmc Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir
    Jennifer Baker
    Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA
    Am J Addict 19:17-29. 2010
    ..Buprenorphine had no significant effect on NRTI concentrations. Concomitant use of buprenorphine with ddI, 3TC, or TDF results in neither a significant pharmacokinetic nor pharmacodynamic interaction...
  11. doi request reprint Interactions between alcohol and the HIV entry inhibitor Maraviroc
    Valerie A Gruber
    Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA
    J Int Assoc Provid AIDS Care 12:375-7. 2013
    ..The present study evaluated the effects of alcohol on maraviroc pharmacokinetics and the effects of maraviroc on alcohol pharmacokinetics...
  12. ncbi request reprint Office-based buprenorphine treatment for opioid-dependent patients
    Elinore F McCance-Katz
    Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA
    Harv Rev Psychiatry 12:321-38. 2004
    ....
  13. doi request reprint Team-based learning exercise efficiently teaches brief intervention skills to medicine residents
    Maria A Wamsley
    a Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA
    Subst Abus 34:344-9. 2013
    ..This study examined whether a 3-hour SBI curriculum for internal medicine residents utilizing a team-based learning (TBL) format is effective for SBI skills as measured by a standardized patient (SP) assessment...
  14. doi request reprint Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals
    Carmen L Masson
    Department of Psychiatry, University of California, San Francisco, California
    Am J Addict 23:34-40. 2014
    ..The purpose of this study was to examine the effect of hepatitis C virus (HCV) infection on buprenorphine pharmacokinetics in opioid-dependent, buprenorphine/naloxone-maintained adults...
  15. pmc Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review
    Suneel M Agerwala
    University of California, San Francisco, Addiction Medicine Research, Department of Psychiatry, San Francisco, CA, USA
    J Psychoactive Drugs 44:307-17. 2012
    ..Screening large numbers of individuals presents an opportunity to engage those who are in need of treatment. However, additional research is needed to determine how best to implement SBIRT...
  16. ncbi request reprint A primary care approach to substance misuse
    Brad Shapiro
    University of California, San Francisco, School of Medicine, San Francisco, CA, USA
    Am Fam Physician 88:113-21. 2013
    ..The use of a motivational rather than a confrontational communication style during screening, counseling, and treatment is important to improve patient outcomes. ..
  17. doi request reprint Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residents
    Jason M Satterfield
    Division of General Internal Medicine, University of California San Francisco, San Francisco, California 94143, USA
    Subst Abus 33:303-7. 2012
    ..Residents made moderate improvements in brief intervention skills. Future SBIRT curricular evaluations would ideally include a controlled comparison with larger samples from multiple institutions...
  18. ncbi request reprint Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients
    Alison Oliveto
    Department of Psychiatry, Yale School of Medicine and the VA CT Healthcare System, West Haven, CT, USA
    Drug Alcohol Depend 79:157-65. 2005
    ..These results suggest that an efficacious maintenance dose is necessary for contingencies to be effective in facilitating both opioid and cocaine abstinence...

Research Grants29

  1. Opioids & HIV Medications: Interactions in Drug Abusers
    Elinore McCance Katz; Fiscal Year: 2007
    ..Drug interaction studies of the type proposed have been identified as a priority research area for NIDA because of their importance to optimizing the clinical care of HIV disease in opioid dependent patients. ..
  2. Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV
    Elinore McCance Katz; Fiscal Year: 2007
    ....
  3. Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection
    Elinore McCance Katz; Fiscal Year: 2009
    ..The proposed studies will inform clinical treatment of comorbid HIV/AIDS, Hepatitis C and alcohol use/abuse leading to improved clinical outcomes and reduced risk of HIV transmission. ..
  4. Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection
    Elinore F McCance Katz; Fiscal Year: 2010
    ..The proposed studies will inform clinical treatment of comorbid HIV/AIDS, Hepatitis C and alcohol use/abuse leading to improved clinical outcomes and reduced risk of HIV transmission. ..
  5. Disulfiram Interactions With HIV Medications: Clinical Implications
    Elinore F McCance Katz; Fiscal Year: 2010
    ....
  6. OPIOIDS AND HIV MEDICATIONS--INTERACTIONS IN DRUG ABUSER
    Elinore McCance Katz; Fiscal Year: 2003
    ..abstract_text> ..
  7. COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTS
    Elinore McCance Katz; Fiscal Year: 2002
    ..In total, these studies should provide significant contributions to the current state of knowledge regarding the epidemiology of cocaine-alcohol abuse and treatment of these disorders. ..
  8. COCAETHYLENE COCAINE AGONIST THERAPY/TOLERANCE INDUCTION
    Elinore McCance Katz; Fiscal Year: 2002
    ..Positive findings from these studies could be followed in future studies with clinical trials to assess the efficacy of this class of drugs in the treatment of cocaine dependence. ..
  9. Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection
    Elinore F McCance Katz; Fiscal Year: 2011
    ..The proposed studies will inform clinical treatment of comorbid HIV/AIDS, Hepatitis C and alcohol use/abuse leading to improved clinical outcomes and reduced risk of HIV transmission. ..